-
August 19, 2008 Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus® Brand in the US
-
July 31, 2008 Lupin receives USFDA approval for Divalproex Sodium Delayed-Release Tablets
-
July 30, 2008 Lupin Makes an Acquisition in Germany
-
June 26, 2008 Lupin appoints New NCE Research Head
-
June 26, 2008 Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for SUPRAX® 400 mg Tablets in the U.S.
-
June 16, 2008 Lupin receives USFDA approval for Escitalopram Oxalate Tablets
-
May 30, 2008 Lupin receives USFDA Approval for Topiramate Tablets
-
May 14, 2008 Lupin FY 2007-08 Consolidated Net Profit up 32% to Rs. 4083 mn
-
April 28, 2008 Lupin Launches SUPRAX ®400 mg Tablets in the US
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications